Benin Management Corp’s AbbVie ABBV Stock Holding History

Benin Management Corp’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$349K	Buy	1,385 +173	+14%	+$37.2K	0.07%	117
2026 Q1	$264K	Buy	1,212 +25	+2%	+$5.55K	0.06%	125
2025 Q4	$271K	Hold	1,187	–	–	0.06%	115
2025 Q3	$275K	Hold	1,187	–	–	0.07%	111
2025 Q2	$220K	Sell	1,187 -23	-2%	-$4.28K	0.06%	122
2025 Q1	$254K	Buy	1,210 +35	+3%	+$6.8K	0.07%	108
2024 Q4	$209K	Hold	1,175	–	–	0.06%	119
2024 Q3	$232K	Sell	1,175 -120	-9%	-$22.4K	0.07%	113
2024 Q2	$222K	Sell	1,295 -177	-12%	-$29.3K	0.07%	111
2024 Q1	$268K	Buy	1,472 +36	+3%	+$6.2K	0.08%	93
2023 Q4	$223K	Buy	+1,436	New	+$209K	0.08%	99
2023 Q2	–	Sell	-5,850	Closed	-$932K	–	98
2023 Q1	$932K	Hold	5,850	–	–	0.35%	38
2022 Q4	$945K	Hold	5,850	–	–	0.38%	34
2022 Q3	$785K	Hold	5,850	–	–	0.33%	39
2022 Q2	$896K	Hold	5,850	–	–	0.34%	37
2022 Q1	$948K	Hold	5,850	–	–	0.29%	39
2021 Q4	$792K	Hold	5,850	–	–	0.24%	52
2021 Q3	$631K	Hold	5,850	–	–	0.2%	58
2021 Q2	$659K	Hold	5,850	–	–	0.21%	57
2021 Q1	$633K	Sell	5,850 -200	-3%	-$21.4K	0.22%	53
2020 Q4	$648K	Hold	6,050	–	–	0.26%	49
2020 Q3	$530K	Sell	6,050 -500	-8%	-$47.1K	0.24%	53
2020 Q2	$643K	Sell	6,550 -100	-2%	-$8.8K	0.29%	44
2020 Q1	$507K	Buy	6,650 +100	+2%	+$8.52K	0.26%	51
2019 Q4	$580K	Sell	6,550 -1,100	-14%	-$91.3K	0.24%	54
2019 Q3	$579K	Buy	7,650 +150	+2%	+$10.3K	0.24%	49
2019 Q2	$545K	Buy	7,500 +1,500	+25%	+$118K	0.23%	51
2019 Q1	$484K	Hold	6,000	–	–	0.21%	58
2018 Q4	$553K	Buy	6,000 +150	+3%	+$13.2K	0.27%	49
2018 Q3	$553K	Hold	5,850	–	–	0.22%	54
2018 Q2	$542K	Hold	5,850	–	–	0.24%	53
2018 Q1	$554K	Buy	5,850 +500	+9%	+$54.9K	0.25%	52
2017 Q4	$517K	Sell	5,350 -1,000	-16%	-$94.2K	0.21%	60
2017 Q3	$564K	Sell	6,350 -112	-2%	-$8.53K	0.23%	57
2017 Q2	$469K	Hold	6,462	–	–	0.2%	60
2017 Q1	$421K	Hold	6,462	–	–	0.19%	68
2016 Q4	$405K	Hold	6,462	–	–	0.19%	76
2016 Q3	$408K	Sell	6,462 -2,000	-24%	-$129K	0.2%	70
2016 Q2	$524K	Buy	8,462 +2,000	+31%	+$122K	0.27%	60
2016 Q1	$369K	Buy	6,462 +112	+2%	+$6.24K	0.2%	70
2015 Q4	$376K	Hold	6,350	–	–	0.21%	65
2015 Q3	$346K	Hold	6,350	–	–	0.19%	69
2015 Q2	$427K	Hold	6,350	–	–	0.23%	61
2015 Q1	$372K	Buy	6,350 +1,700	+37%	+$103K	0.2%	69
2014 Q4	$304K	Buy	4,650 +400	+9%	+$25.2K	0.16%	78
2014 Q3	$246K	Hold	4,250	–	–	0.13%	87
2014 Q2	$240K	Hold	4,250	–	–	0.13%	83
2014 Q1	$219K	Hold	4,250	–	–	0.13%	87
2013 Q4	$224K	Buy	+4,250	New	+$209K	0.14%	82

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Benin Management Corp's ABBV Position: Q2 2026 in Review

Benin Management Corp increased its AbbVie (ABBV) stake by 14% in Q2 2026, buying an estimated $37.2K and bringing the position to 1,385 shares worth $349K. The position accounts for 0.07% of the portfolio, ranked #117.

Benin Management Corp first reported a position in ABBV in Q4 2013 and has held it in 49 quarters since. The position peaked at $948K in Q1 2022. 4,190 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Benin Management Corp held 1,385 shares of AbbVie worth $349K as of Q2 2026.
Benin Management Corp bought 173 AbbVie shares in Q2 2026, an estimated $37.2K.
AbbVie made up 0.07% of Benin Management Corp's portfolio in Q2 2026, its #117 holding.
Benin Management Corp first reported a position in AbbVie in Q4 2013 and has held it in 49 quarters since.
Benin Management Corp's AbbVie position peaked at $948K in Q1 2022.
4,190 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Benin Management Corp's 13F filing for Q2 2026, filed 15 Jul 2026.